Pfizer's Lyrica helps in restless legs syndrome study

(Reuters) - Pfizer Inc's Lyrica pain treatment benefited patients with Restless Legs Syndrome in a late-stage clinical study, the company said on Friday. The Phase III study of more than 700 patients met its three main goals, Pfizer said. Rest...